Headerlogotextwithshieldsshadowed

2023 Course Schedule
Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology

Virtual Meeting


Tuesday, October 24, 2023

10:00 A.M.
 Opening Remarks Rakesh K. Jain
10:10 A.M.
 Tumor Microenvironment I: Angiogenesis and Vascular Function Rakesh K. Jain
11:20 A.M.
 Q&A
11:35 A.M.
 Break
12:00 P.M.
 Tumor Microenvironment II: Vascular Normalization and Immunotherapy  Rakesh K. Jain
1:20 P.M.
 Q&A
1:35 P.M.
 Break
2:00 P.M.
 Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis Rakesh K. Jain
3:20 P.M.
 Q&A
3:35 P.M.
 Break
4:00 P.M.
 Cancer Immunology and Immunotherapy Overview Gordon Freeman
5:05 P.M.
 Q&A
5:20 P.M.
 Adjourn

Wednesday, October 25, 2023

10:00 A.M.
 Circadian Clock  and Metabolic Vulnerabilities of Cancer Chi Van Dang
11:05 A.M.
 Q&A
11:20 A.M.
 Break
12:00 P.M.
 Paradox of the Immune System in Cancer Lisa M. Coussens 
1:05 P.M.
 Q&A
1:20 P.M.
 Break
1:50 P.M.
 Systems approaches to understand mechanisms of tumor immunity in humans Nir Hacohen
2:55 P.M.
 Q&A
3:10 P.M.
 Break
4:00 P.M.
 Mechanisms of Malignant Progression Robert A. Weinberg
5:05 P.M.
 Q&A
5:20 P.M.
 Adjourn

Thursday, October 26, 2023

10:00 A.M.
 Using Cell Transfer to Remodel the Tumor Microenvironment Carl June
11:05 A.M.
 Q&A
11:20 A.M.
 Break
12:00 P.M.
 Monitoring and modulating the microbiome to promote health and end cancer Jennifer Wargo
1:05 P.M.
 Q&A
1:20 P.M.
 Break
2:00 P.M.
 Heterogeneity Through Space and Time Drives the Clinical Behavior of Childhood Brain Tumors Michael D. Taylor
3:05 P.M.
 Q&A
3:20 P.M.
 Break
4:00 P.M.
 Dissecting the Ecosystem of Gliomas by Single-Cell Genomics Mario Suva
5:05 P.M.
 Q&A
5:20 P.M.
 Adjourn

Friday, October 27, 2023

10:00 A.M.
 Determinants of How Tumors Use Metabolism to Support Growth Matthew Vander Heiden
11:05 A.M.
 Q&A
11:20 A.M.
 Break
12:00 P.M.
 Setting in Motion Anti-tumor Immunity: Lessons from the Microenvironment George Coukos
1:05 P.M.
 Q&A
1:20 P.M.
 Break
2:00 P.M.
 Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer David Tuveson
3:05 P.M.
 Q&A
3:20 P.M.
 Break
4:00 P.M.
 Lessons from Clinical Trials of Targeted Therapies for Cancer George W. Sledge, Jr
5:05 P.M.
 Q&A
5:20 P.M.
 Summary and closing remarks Rakesh K. Jain